Compositions and methods for treating the eye

US2021186913A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021186913-A1
Application numberUS-202117189009-A
CountryUS
Kind codeA1
Filing dateMar 1, 2021
Priority dateJul 27, 2018
Publication dateJun 24, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for producing/releasing/delivering/excreting mucin from and/or in the cornea comprising the step of administering a composition comprising: i) a safe and effective amount of a compound and/or extract having retinol-like properties and/or benefits for use in treating dry eye selected from one or more of: botanical extracts, or sources of extracts, from plants of the genus Acronychia, Licaria, Calendula and/or Trigonella ; bacterial extracts, or sources of extracts, of the genus Actinomyces ; and compounds of Formula (I): wherein— the dotted lines represent simple or double bound; optionally one of the dotted line is a double bound; R 1 represent an H, a carbonated chain, linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; R 2 represent a carbonated chain, linear, cyclic ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; optionally a methyl (—CH 3 ) or methylene (═CH 2 ) moiety; a carbonated chain, linear, ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; optionally from 1 to 10 carbon atoms; optionally 6 carbon atoms; optionally an aromatic moiety, optionally a phenyl moiety; optionally 2-methyl-prop-1,3-diene; and ii) optionally, an ophthalmologically acceptable carrier. 2 . The method according to claim 1 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract, or source of extracts, from plants of the genus Acronychia and/or Licaria. 3 . The method according to claim 2 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract, or source of extracts, from plants of the genus Acronychia. 4 . The method according to claim 3 , wherein the botanical extract, or source of extracts, from plants of the genus Acronychia is selected from the group consisting of Acronychia aberram, Acronychia acidula, Acronychia acronychioides, Acronychia acuminate, Acronychia baeuerlenii, Acronychia chooreechillum, Acronychia crassipetala, Acronychia eungellensis, Acronychia imperforate, Acronychia laevis, Acronychia laurifolia, Acronychia littoralis, Acronychia oblongifolia, Acronychia octandra, Acronychia parviflora, Acronychia pauciflora, Acronychia pedunculata, Acronychia pubescens, Acronychia species (Batavia Downs), Acronychia suberosa, Acronychia vestita, Acronychia wilcoxiana , and combinations of two or more thereof. 5 . The method according to claim 4 , wherein the botanical extract, or source of extracts, from plants of the genus Acronychia is Acronychia acidula. 6 . The method according to claim 2 , wherein the botanical extract of Acronychia and/or Licaria comprises from about 1% to about 20%, by weight of the extract, of the compound of formula II wherein: R 1 is selected from the group consisting of C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 3 -C 8 cycloalkyl or aryl; R 2 is selected from the group consisting of hydrogen, hydroxyl, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 8 cycloalkyl or aryl, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC 2 -C 6 alkynyl, —OC 3 -C 8 cycloalkyl or aryl, thiol, —SC 1 -C 6 alkyl, —SC 2 -C 6 alkenyl, —SC 2 -C 6 alkynyl, —SC 3 -C 8 cycloalkyl or aryl, —NR 4 C 1 -C 6 alkyl, —NR 4 C 2 -C 6 alkenyl, —NR 4 C 2 -C 6 alkynyl, and —NR 4 C 3 -C 8 cycloalkyl or aryl; R 3 is selected from —CO 2 H, —CO 2 R 4 or an isosteric equivalent of a carboxy group, wherein R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 3 -C 8 cycloalkyl or aryl; and Y is —(CH 2 —CH 2 )—, —(CH═CH)—, or —(C≡C)—. 7 . The method according to claim 6 , wherein the botanical extract of Acronychia and/or Licaria comprises from about 1% to about 20%, by weight of the extract, of the compound of Formula II wherein: R 1 is selected from the group consisting of C 5 -C 16 alkyl, C 5 -C 16 alkenyl, and C 5 -C 16 alkynyl, more preferably C 5 -C 16 alkenyl, including, for example, farnesyl; R 2 is selected from the group consisting of hydrogen, hydroxyl, —OC 1 -C 6 alkyl, —OC 2 -C 6 alkenyl, —OC 2 -C 6 alkynyl, —OC 3 -C 8 cycloalkyl, more preferably hydrogen, hydroxyl, —OC 1 -C 6 alkyl, even more preferably hydrogen or —OC 1 -C 3 alkyl; R 3 is selected from —CO 2 H, —CO 2 R 4 wherein R 4 is C 1 -C 6 alkyl, or an isosteric equivalent of a carboxy group; and Y is —(CH 2 —CH 2 )— or —(CH═CH)—. 8 . The method according to claim 7 , wherein the compound of formula (II) are in the form of an acid or alkylester selected from 3-(4-farnesyloxyphenyl)-propionic acid, 3-(4-farnesyloxy-3-hydroxyphenyl)-propionic acid, 3-(4-farnesyloxy-3-methoxyphenyl)-propionic acid, alkylesters thereof and combinations of two or more thereof. 9 . The method according to claim 8 , wherein the compound of Formula II useful in the present invention is 3-(4-farnesyloxyphenyl)-propionic acid and/or its ethyl ester. 10 . The method according to claim 2 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract, or source of extracts, from plants of the genus Licaria. 11 . The method according to claim 10 , wherein the botanical extract, or source of extracts, from plants of the genus Licaria is selected from the group consisting of Licaria vernicosa, Licaria brittoniana, Licaria canella, Licaria cubensis, Licaria velutina and Licaria triandra , and combinations of two or more thereof. 12 . The method according to claim 11 , wherein the botanical extract, or source of extracts, from plants of the genus Licaria is Licaria vernicosa. 13 . The method according to claim 1 , wherein the compound and/or extract having retinol-like properties and/or benefits is a bacterial extract, or source of extracts, of the genus Actinomyces. 14 . The method according to claim 13 , wherein the compound and/or extract having retinol-like properties and/or benefits is a bacterial extract, or source of extracts, of the Actinomyces species A5640. 15 . The method according to claim 1 , wherein the compound and/or extract having retinol-like properties and/or benefits comprises the compound of Formula (I): wherein— the dotted lines represent simple or double bound; optionally, one of the dotted line is a double bound; R 1 represent an H, a carbonated chain, linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; R 2 represent a carbonated chain, linear, cyclic ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; a carbonated chain, linear, ringed, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms. 16 . The method according to claim 15 , wherein the compound of Formula I is selected from (2E,4E,6E)-7-(1,1,2,2,3,3-hexamethyl-2,3-dihydro-1H-inden-5-yl)-3-methylocta-2,4,6-trienoic acid and 4-(1-(1,1,2,2,3,3-hexamethyl-2,3-dihydro-1H-inden-5-yl)vinyl)benzoic acid and thei

Assignees

Inventors

Classifications

  • Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea · CPC title

  • Lauraceae (Laurel family), e.g. cinnamon or sassafras · CPC title

  • Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

  • Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae · CPC title

  • Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021186913A1 cover?
The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
Who is the assignee on this patent?
Johnson & Johnson Surgical Vision Inc
What technology area does this patent fall under?
Primary CPC classification A61K31/203. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jun 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).